Jinjin Xu

3.5k total citations · 1 hit paper
63 papers, 2.3k citations indexed

About

Jinjin Xu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Jinjin Xu has authored 63 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 11 papers in Pathology and Forensic Medicine and 11 papers in Cancer Research. Recurrent topics in Jinjin Xu's work include Cardiac Ischemia and Reperfusion (11 papers), MicroRNA in disease regulation (9 papers) and Circular RNAs in diseases (7 papers). Jinjin Xu is often cited by papers focused on Cardiac Ischemia and Reperfusion (11 papers), MicroRNA in disease regulation (9 papers) and Circular RNAs in diseases (7 papers). Jinjin Xu collaborates with scholars based in China, United States and Hong Kong. Jinjin Xu's co-authors include Yaochu Jin, Shiqing Liu, Hangyu Zhu, Shanliang Zhong, Jianhua Zhao, Shaoqing Lei, Zhongyuan Xia, Zhengyuan Xia, Jinhai Tang and Zhiyuan Chen and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jinjin Xu

62 papers receiving 2.3k citations

Hit Papers

Federated learning on non-IID data: A survey 2021 2026 2022 2024 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinjin Xu China 27 1.0k 519 514 252 200 63 2.3k
Núria Queralt-Rosiñach Spain 13 2.2k 2.1× 377 0.7× 363 0.7× 87 0.3× 142 0.7× 26 3.2k
Xuejiao Liu China 28 755 0.7× 124 0.2× 231 0.4× 130 0.5× 249 1.2× 113 2.0k
Tingting He China 26 1.4k 1.4× 286 0.6× 354 0.7× 69 0.3× 195 1.0× 201 2.7k
Yühong Huang China 27 1.2k 1.1× 104 0.2× 198 0.4× 129 0.5× 146 0.7× 155 2.7k
Hongliang Liang China 23 610 0.6× 142 0.3× 177 0.3× 178 0.7× 181 0.9× 91 2.0k
Ping Xiong China 24 601 0.6× 130 0.3× 429 0.8× 94 0.4× 201 1.0× 127 2.1k
Fei Zhou China 30 899 0.9× 173 0.3× 447 0.9× 226 0.9× 214 1.1× 219 3.1k
Qi Huang China 24 485 0.5× 338 0.7× 227 0.4× 50 0.2× 197 1.0× 164 2.3k
Kunlun He China 33 1.6k 1.5× 351 0.7× 281 0.5× 103 0.4× 675 3.4× 236 4.1k
Javier Garcı́a-Garcı́a Spain 18 1.7k 1.7× 83 0.2× 275 0.5× 77 0.3× 133 0.7× 46 2.6k

Countries citing papers authored by Jinjin Xu

Since Specialization
Citations

This map shows the geographic impact of Jinjin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinjin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinjin Xu more than expected).

Fields of papers citing papers by Jinjin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinjin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinjin Xu. The network helps show where Jinjin Xu may publish in the future.

Co-authorship network of co-authors of Jinjin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinjin Xu. A scholar is included among the top collaborators of Jinjin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinjin Xu. Jinjin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weng, Zhi, et al.. (2024). A segmentation-based algorithm for classification of benign and malignancy Thyroid nodules with multi-feature information. Biomedical Engineering Letters. 14(4). 785–800. 3 indexed citations
2.
Su, Tianyi, et al.. (2023). A novel ultrasound image diagnostic method for thyroid nodules. Scientific Reports. 13(1). 1654–1654. 8 indexed citations
3.
Zhang, Le, Jinjin Xu, Muxuan Li, & Xiujuan Chen. (2023). The role of long noncoding RNAs in liquid–liquid phase separation. Cellular Signalling. 111. 110848–110848. 6 indexed citations
4.
Xu, Jinjin, Lingjia Kong, Bihua Li, et al.. (2023). Constitutively active autophagy in macrophages dampens inflammation through metabolic and post-transcriptional regulation of cytokine production. Cell Reports. 42(7). 112708–112708. 16 indexed citations
5.
Xu, Jinjin, Xin Chen, Sai Zhu, et al.. (2022). Myc-mediated circular RNA circMcph1/miR-370-3p/Irak2 axis is a progressive regulator in hepatic fibrosis. Life Sciences. 312. 121182–121182. 8 indexed citations
6.
Zhu, Hangyu, Jinjin Xu, Shiqing Liu, & Yaochu Jin. (2021). Federated learning on non-IID data: A survey. Neurocomputing. 465. 371–390. 543 indexed citations breakdown →
7.
Yang, Jing, Zifei Qin, Shishi Li, et al.. (2019). Mechanism of the efflux transport of demethoxycurcumin-O-glucuronides in HeLa cells stably transfected with UDP-glucuronosyltransferase 1A1. PLoS ONE. 14(5). e0217695–e0217695. 5 indexed citations
11.
Su, Wating, Yuan Zhang, Jinjin Xu, et al.. (2016). N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats. Cardiovascular Diabetology. 15(1). 146–146. 49 indexed citations
12.
13.
Xu, Jinjin, Wenjing Li, Shanliang Zhong, et al.. (2014). [Extraction and identification of exosomes from drug-resistant breast cancer cells and their potential role in cell-to-cell drug-resistance transfer].. PubMed. 36(3). 165–70. 1 indexed citations
14.
Xu, Jinjin, Haobo Li, Michael G. Irwin, et al.. (2014). Propofol Ameliorates Hyperglycemia-Induced Cardiac Hypertrophy and Dysfunction via Heme Oxygenase-1/Signal Transducer and Activator of Transcription 3 Signaling Pathway in Rats*. Critical Care Medicine. 42(8). e583–e594. 31 indexed citations
15.
Hou, Jingbo, Zhengyuan Xia, Wenjing Zeng, et al.. (2013). Recombinant PTD-Cu/Zn SOD attenuates hypoxia–reoxygenation injury in cardiomyocytes. Free Radical Research. 47(5). 386–393. 24 indexed citations
16.
Chen, Wei‐xian, Qing Hu, Mantang Qiu, et al.. (2013). miR-221/222: promising biomarkers for breast cancer. Tumor Biology. 34(3). 1361–1370. 100 indexed citations
17.
Zhong, Shanliang, Wenjing Li, Zhiyuan Chen, Jinjin Xu, & Jianhua Zhao. (2013). miR-222 and miR-29a contribute to the drug-resistance of breast cancer cells. Gene. 531(1). 8–14. 126 indexed citations
18.
Sun, Qianyun, Fu‐Mei Yang, Yue‐Hu Wang, et al.. (2011). Bioactive Isoquinoline Alkaloids fromCorydalis saxicola. Planta Medica. 78(1). 65–70. 52 indexed citations
19.
Xia, Rui, Bo Zhao, Yang Wu, et al.. (2011). Ginsenoside Rb1 Preconditioning Enhances eNOS Expression and Attenuates Myocardial Ischemia/Reperfusion Injury in Diabetic Rats. BioMed Research International. 2011(1). 767930–767930. 70 indexed citations
20.
Wu, Yang, Zhongyuan Xia, Juan Dou, et al.. (2010). Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats. Molecular Biology Reports. 38(7). 4327–4335. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026